Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up.
The aim of this study was to compare the clinical outcomes between thulium laser enucleation of the prostate (ThuLEP) and plasmakinetic bipolar resection of the prostate (PKRP) for treating benign prostatic hyperplasia (BPH) in a prospective randomized trial with 5 years of follow-up. One hundred fifty-eight consecutive patients with BPH were randomized to receive operation of either ThuLEP (n = 79) or PKRP (n = 79). All cases were evaluated preoperatively, and a part of them were evaluated at 3-5 years postoperatively by the International Prostate Symptom Score (IPSS), quality of life score (QoLS), maximum flow rate (Qmax), and postvoid residual (PVR) urine volume. Eighty patients completed the 5-year follow-up. Each study arm showed no significant difference in preoperative parameters. Compared with PKRP, ThuLEP required longer operation time (65.4 vs 47.4 min, p = 0.022) but resulted in less hemoglobin decrease (1.5 vs 3.0 g/L, p = 0.045), catheterization time (2.1 vs 3.5 days, p = 0.031), irrigated volume (12.4 vs 27.2 L, p = 0.022), and hospital stay (2.5 vs 4.6 days, p = 0.026). During the 60-month follow-up, both procedures demonstrated no significant difference in terms of Qmax, IPSS, PVR urine volume, and QoLS. ThuLEP was statistically superior to PKRP in blood loss, catheterization time, irrigated volume, and hospital stay but inferior to PKRP in operation time. However, both procedures showed no significant difference in terms of Qmax, IPSS, PVR urine volume, and QoLS through the 60-month follow-up.
Department of Urology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, 430071, China.
Zhonghua
Z
Yang
Department of Urology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, 430071, China.
Tongzu
T
Liu
Department of Urology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, 430071, China. wangxinghuan@whu.edu.cn.
Xinghuan
X
Wang
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D061646:Operative Time; D011446:Prospective Studies; D011470:Prostatic Hyperplasia / Q000601:surgery*; D011788:Quality of Life; D013932:Thulium
D013932:Thulium
BPH; PKRP; TURP; Thulium laser
Can J Urol. 2015 Oct;22 Suppl 1:30-44
26497342
Urol J. 2015 Dec 23;12(6):2452-6
26706745
Curr Bladder Dysfunct Rep. 2010 Dec;5(4):212-218
21475707
Lasers Med Sci. 2014 May;29(3):1093-8
24189927
Eur Urol. 2009 Nov;56(5):798-809
19595501
Rev Col Bras Cir. 2015 Jun;42(3):165-70
26291257
Lasers Med Sci. 2016 Apr;31(3):485-95
26868032
BJU Int. 2005 Jan;95(1):69-71
15638897
J Urol. 2010 Aug;184(2):635-40
20639029
Lasers Med Sci. 2014 Mar;29(2):689-93
23828495
Eur Urol. 2015 Jun;67(6):1066-1096
24972732
Sci Rep. 2016 Feb 19;6:21494
26892901
Eur Urol. 2009 Nov;56(5):796-7
19660854
Eur Urol. 2008 Feb;53(2):382-89
17566639
J Endourol. 2016 Jan;30(1):97-101
26352136
Scand J Urol Nephrol Suppl. 1984;82:1-80
6207590
Urology. 2013 Feb;81(2):396-400
23374815
Eur Urol. 2010 Sep;58(3):349-55
20605316
Scand J Urol Nephrol. 2008;42(3):265-8
17934987
BJU Int. 2010 Jun;105(11):1560-4
19912211
J Urol. 2008 Jul;180(1):246-9
18499179